| INNOVENT BIOLOGICS INC. |
| China |
| Gesundheit |
| KYG4818G1010 / A2N7N8 |
| 6IB (Frankfurt) |
| FRA:6IB, ETR:6IB, 6IB:GR |
| - |
| https://en.innoventbio.co.. |
|
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, ..
>Volltext.. |
| 19466.28 Mio. EUR |
| 17188.66 Mio. EUR |
| 1967.68 Mio. EUR |
| 415.95 Mio. EUR |
| 157.31 Mio. EUR |
| 0.09 EUR |
| 300.45 Mio. EUR |
| 2247.73 Mio. EUR |
| - |
| 2.15 |
| 47.26% |
| 19.02% |
| - |
| - |
| - |
| - |
| INNOVENT BIOLOGICS, INNOVENT BIO |
| 28.09.26 |
|
||||
|
||||
|